Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa, Connie P.M. Duong, Maryam Tidjani Alou, Romain Daillère, Aurélie Fluckiger, Meriem Messaoudene, Conrad Rauber, María Paula Roberti, Marine Fidelle, Caroline Flament, Vichnou Poirier-Colame, Paule Opolon, Christophe Klein, Kristina Iribarren, Laura Mondragón, Nicolas Jacquelot, Bo Qu, Gladys Ferrere, Céline Clémenson, Laura Mezquita, J. Remon Masip, Charles Naltet, Solenn Brosseau, Courèche Kaderbhaï, Corentin Richard, Hira Rizvi, Florence Levenez, Nathalie Galleron, Benoît Quinquis, Nicolas Pons, Bernhard Ryffel, Véronique Minard-Colin, Patrick Gonin, Jean‐Charles Soria, Éric Deutsch, Yohann Loriot, François Ghiringhelli, Gérard Zalcman, François Goldwasser, Bernard Escudier, Matthew D. Hellmann, Alexander Eggermont, Didier Raoult, Laurence Albigès, Guido Guido Kroemer, Laurence Zitvogel (2017). Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors. , 359(6371), DOI: https://doi.org/10.1126/science.aan3706.
Article315 days agoAssociation of Lung Immune Prognostic Index (LIPI) with Disease Control Rate and Progression-Free Survival in Patients with Soft-Tissue Sarcoma Treated with Immunotherapy in Early-Phase Trials
Marianne Zoghbi, Bharti Patel, Matthieu Roulleaux Dugage, Laura Mezquita, Rastilav Bahleda, Armelle Dufresne, Mehdi Brahmi, Isabelle Ray‐Coquard, Patricia Pautier, Jean Yves Blay, Axel Le Cesne, Christophe Massard, Benjamin Besse, Édouard Auclin, Elise F. Nassif (2024). Association of Lung Immune Prognostic Index (LIPI) with Disease Control Rate and Progression-Free Survival in Patients with Soft-Tissue Sarcoma Treated with Immunotherapy in Early-Phase Trials. , 16(23), DOI: https://doi.org/10.3390/cancers16234053.
Article49 days agoData from Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with <i>BRAF</i>-Mutant Metastatic Non–Small Cell Lung Cancer
Sandra Ortiz‐Cuaran, Laura Mezquita, Aurélie Swalduz, Mihaela Aldea, Julien Mazières, Camille Léonce, Cécile Jovelet, Anne Pradines, Virginie Avrillon, Washington R. Chumbi Flores, Ludovic Lacroix, Yohann Loriot, Virginie Westeel, Maud Ngo‐Camus, Claire Tissot, C. Raynaud, Radj Gervais, Étienne Brain, I. Monnet, Etienne Giroux‐Leprieur, Caroline Caramella, Céline Mahier‐Ait Oukhatar, Natalie Hoog-Labouret, Frank de Kievit, Karen Howarth, Clive Morris, Emma Green, Luc Friboulet, Sylvie Chabaud, Jean‐François Guichou, M. Pérol, Benjamin Besse, Jean Yves Blay, Pierre Saintigny, David Planchard (2023). Data from Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with <i>BRAF</i>-Mutant Metastatic Non–Small Cell Lung Cancer. , DOI: https://doi.org/10.1158/1078-0432.c.6530096.
Preprint49 days agoSupplementary Data from Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with <i>BRAF</i>-Mutant Metastatic Non–Small Cell Lung Cancer
Sandra Ortiz‐Cuaran, Laura Mezquita, Aurélie Swalduz, Mihaela Aldea, Julien Mazières, Camille Léonce, Cécile Jovelet, Anne Pradines, Virginie Avrillon, Washington R. Chumbi Flores, Ludovic Lacroix, Yohann Loriot, Virginie Westeel, Maud Ngo‐Camus, Claire Tissot, C. Raynaud, Radj Gervais, Étienne Brain, I. Monnet, Etienne Giroux‐Leprieur, Caroline Caramella, Céline Mahier‐Ait Oukhatar, Natalie Hoog-Labouret, Frank de Kievit, Karen Howarth, Clive Morris, Emma Green, Luc Friboulet, Sylvie Chabaud, Jean‐François Guichou, M. Pérol, Benjamin Besse, Jean Yves Blay, Pierre Saintigny, David Planchard (2023). Supplementary Data from Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with <i>BRAF</i>-Mutant Metastatic Non–Small Cell Lung Cancer. , DOI: https://doi.org/10.1158/1078-0432.22478981.
Preprint47 days agoData from Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with <i>BRAF</i>-Mutant Metastatic Non–Small Cell Lung Cancer
Sandra Ortiz‐Cuaran, Laura Mezquita, Aurélie Swalduz, Mihaela Aldea, Julien Mazières, Camille Léonce, Cécile Jovelet, Anne Pradines, Virginie Avrillon, Washington R. Chumbi Flores, Ludovic Lacroix, Yohann Loriot, Virginie Westeel, Maud Ngo‐Camus, Claire Tissot, C. Raynaud, Radj Gervais, Étienne Brain, I. Monnet, Etienne Giroux‐Leprieur, Caroline Caramella, Céline Mahier‐Ait Oukhatar, Natalie Hoog-Labouret, Frank de Kievit, Karen Howarth, Clive Morris, Emma Green, Luc Friboulet, Sylvie Chabaud, Jean‐François Guichou, M. Pérol, Benjamin Besse, Jean Yves Blay, Pierre Saintigny, David Planchard (2023). Data from Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with <i>BRAF</i>-Mutant Metastatic Non–Small Cell Lung Cancer. , DOI: https://doi.org/10.1158/1078-0432.c.6530096.v1.
Preprint47 days ago